|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 14 2535-2544, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
AA Hack, MY Lam, L Cordier, DI Shoturma, CT Ly, MA Hadhazy, MR Hadhazy, HL Sweeney and EM McNally
Department of Molecular Genetics and Cell Biology, Section of Cardiology, University of Chicago, Chicago, IL 60637, USA.
Sarcoglycan is a multimeric, integral membrane glycoprotein complex that associates with dystrophin. Mutations in individual sarcoglycan subunits have been identified in inherited forms of muscular dystrophy. To evaluate the contributions of sarcoglycan and dystrophin to muscle membrane stability and muscular dystrophy, we compared muscle lacking specific sarcoglycans or dystrophin. Here we report that mice lacking (delta)-sarcoglycan developed muscular dystrophy and cardiomyopathy similar to mice lacking (gamma)-sarcoglycan. However, unlike muscle lacking (gamma)-sarcoglycan, (delta)-sarcoglycan-deficient muscle was sensitive to eccentric contraction-induced disruption of the plasma membrane. In the absence of (delta)-sarcoglycan, (alpha)-, (beta)- and (gamma)-sarcoglycan were undetectable, while dystrophin was expressed at normal levels. In contrast, without (gamma)-sarcoglycan, reduced levels of (alpha)-, (beta)- and (delta)-sarcoglycan were expressed, glycosylated and formed a complex with each other. Thus, the elimination of (gamma)- and (delta)-sarcoglycan had different molecular consequences for the assembly and function of the dystrophin-glycoprotein complex. Furthermore, these molecular differences were associated with different mechanical consequences for the muscle plasma membrane. Through this in vivo analysis, a model for sarcoglycan assembly is proposed.
This article has been cited by other articles:
![]() |
R. L. Gundry, K. Raginski, Y. Tarasova, I. Tchernyshyov, D. Bausch-Fluck, S. T. Elliott, K. R. Boheler, J. E. Van Eyk, and B. Wollscheid The Mouse C2C12 Myoblast Cell Surface N-Linked Glycoproteome: IDENTIFICATION, GLYCOSITE OCCUPANCY, AND MEMBRANE ORIENTATION Mol. Cell. Proteomics, November 1, 2009; 8(11): 2555 - 2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jaeger, K. J. Sonnemann, D. P. Fitzsimons, K. W. Prins, and J. M. Ervasti Context-dependent functional substitution of {alpha}-skeletal actin by {gamma}-cytoplasmic actin FASEB J, July 1, 2009; 23(7): 2205 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Goehringer, D. Rutschow, R. Bauer, S. Schinkel, D. Weichenhan, R. Bekeredjian, V. Straub, J. A. Kleinschmidt, H. A. Katus, and O. J. Muller Prevention of cardiomyopathy in {delta}-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors Cardiovasc Res, June 1, 2009; 82(3): 404 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, C. Long, Y. Yue, and D. Duan Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice Hum. Mol. Genet., April 1, 2009; 18(7): 1209 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Q. Wallace, K. A. Lapidos, J. S. Kenik, and E. M. McNally Long-Term Survival of Transplanted Stem Cells in Immunocompetent Mice with Muscular Dystrophy Am. J. Pathol., September 1, 2008; 173(3): 792 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gastaldello, S. D'Angelo, S. Franzoso, M. Fanin, C. Angelini, R. Betto, and D. Sandona Inhibition of Proteasome Activity Promotes the Correct Localization of Disease-Causing {alpha}-Sarcoglycan Mutants in HEK-293 Cells Constitutively Expressing {beta}-, {gamma}-, and {delta}-Sarcoglycan Am. J. Pathol., July 1, 2008; 173(1): 170 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hijikata, A. Nakamura, K. Isokawa, M. Imamura, K. Yuasa, R. Ishikawa, K. Kohama, S. Takeda, and H. Yorifuji Plectin 1 links intermediate filaments to costameric sarcolemma through {beta}-synemin, {alpha}-dystrobrevin and actin J. Cell Sci., June 15, 2008; 121(12): 2062 - 2074. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kobuke, F. Piccolo, K. W. Garringer, S. A. Moore, E. Sweezer, B. Yang, and K. P. Campbell A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice Hum. Mol. Genet., May 1, 2008; 17(9): 1201 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sharma, T. Tran, G. L. Stelmack, K. McNeill, R. Gosens, M. M. Mutawe, H. Unruh, W. T. Gerthoffer, and A. J. Halayko Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L57 - L68. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Allikian, G. Bhabha, P. Dospoy, A. Heydemann, P. Ryder, J. U. Earley, M. J. Wolf, H. A. Rockman, and E. M. McNally Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants Hum. Mol. Genet., December 1, 2007; 16(23): 2933 - 2943. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Parsons, D. P. Millay, M. A. Sargent, F. J. Naya, E. M. McNally, H. L. Sweeney, and J. D. Molkentin Genetic Disruption of Calcineurin Improves Skeletal Muscle Pathology and Cardiac Disease in a Mouse Model of Limb-Girdle Muscular Dystrophy J. Biol. Chem., March 30, 2007; 282(13): 10068 - 10078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heydemann, A. Demonbreun, M. Hadhazy, J. U. Earley, and E. M. McNally Nuclear sequestration of {delta}-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes Hum. Mol. Genet., February 15, 2007; 16(4): 355 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fiaccavento, F. Carotenuto, M. Minieri, L. Masuelli, A. Vecchini, R. Bei, A. Modesti, L. Binaglia, A. Fusco, A. Bertoli, et al. {alpha}-Linolenic Acid-Enriched Diet Prevents Myocardial Damage and Expands Longevity in Cardiomyopathic Hamsters Am. J. Pathol., December 1, 2006; 169(6): 1913 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoshijima, R. Knoll, M. Pashmforoush, and K. R. Chien Reversal of Calcium Cycling Defects in Advanced Heart Failure: Toward Molecular Therapy J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A15 - A23. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Hoffman and D. Escolar Translating Mighty Mice into Neuromuscular Therapeutics: Is Bigger Muscle Better? Am. J. Pathol., June 1, 2006; 168(6): 1775 - 1778. [Full Text] [PDF] |
||||
![]() |
S. A. Parsons, D. P. Millay, M. A. Sargent, E. M. McNally, and J. D. Molkentin Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular Dystrophy Am. J. Pathol., June 1, 2006; 168(6): 1975 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rooney, J. V. Welser, M. A. Dechert, N. L. Flintoff-Dye, S. J. Kaufman, and D. J. Burkin Severe muscular dystrophy in mice that lack dystrophin and {alpha}7 integrin J. Cell Sci., June 1, 2006; 119(11): 2185 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kondoh, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Kitagawa-Sakakida, I. A. Memon, N. Kawaguchi, N. Matsuura, and H. Matsuda Reorganization of cytoskeletal proteins and prolonged life expectancy caused by hepatocyte growth factor in a hamster model of late-phase dilated cardiomyopathy J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 295 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Allikian, A. A. Hack, S. Mewborn, U. Mayer, and E. M. McNally Genetic compensation for sarcoglycan loss by integrin {alpha}7{beta}1 in muscle J. Cell Sci., August 1, 2004; 117(17): 3821 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lapidos, R. Kakkar, and E. M. McNally The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma Circ. Res., April 30, 2004; 94(8): 1023 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Wheeler, C. E. Korcarz, K. A. Collins, K. A. Lapidos, A. A. Hack, M. R. Lyons, S. Zarnegar, J. U. Earley, R. M. Lang, and E. M. McNally Secondary Coronary Artery Vasospasm Promotes Cardiomyopathy Progression Am. J. Pathol., March 1, 2004; 164(3): 1063 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. X Nguyen and J. G Tidball Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice J. Physiol., December 15, 2003; 553(3): 833 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. X Nguyen and J. G Tidball Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice J. Physiol., July 15, 2003; 550(2): 347 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Boito, M Fanin, G Siciliano, C Angelini, and E Pegoraro Novel sarcoglycan gene mutations in a large cohort of Italian patients J. Med. Genet., May 1, 2003; 40(5): e67 - 67. [Full Text] [PDF] |
||||
![]() |
M. T. Wheeler, S. Zarnegar, and E. M. McNally {zeta}-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy Hum. Mol. Genet., September 1, 2002; 11(18): 2147 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Watchko, T. L. O'Day, and E. P. Hoffman Functional characteristics of dystrophic skeletal muscle: insights from animal models J Appl Physiol, August 1, 2002; 93(2): 407 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle Physiol Rev, April 1, 2002; 82(2): 291 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Cote, H. Moukhles, and S. Carbonetto Dystroglycan Is Not Required for Localization of Dystrophin, Syntrophin, and Neuronal Nitric-oxide Synthase at the Sarcolemma but Regulates Integrin alpha 7B Expression and Caveolin-3 Distribution J. Biol. Chem., February 8, 2002; 277(7): 4672 - 4679. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.T. WHEELER, M.J. ALLIKIAN, A. HEYDEMANN, and E.M. MCNALLY The Sarcoglycan Complex in Striated and Vascular Smooth Muscle Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 389 - 398. [Abstract] [PDF] |
||||
![]() |
E. P. Moiseeva Adhesion receptors of vascular smooth muscle cells and their functions Cardiovasc Res, December 1, 2001; 52(3): 372 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Royuela, G. Hugon, F. Rivier, J. A. Fehrentz, J. Martinez, R. Paniagua, and D. Mornet Variations in Dystrophin Complex in Red and White Caudal Muscles from Torpedo marmorata J. Histochem. Cytochem., July 1, 2001; 49(7): 857 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Barresi, S. A. Moore, C. A. Stolle, J. R. Mendell, and K. P. Campbell Expression of gamma -Sarcoglycan in Smooth Muscle and Its Interaction with the Smooth Muscle Sarcoglycan-Sarcospan Complex J. Biol. Chem., December 1, 2000; 275(49): 38554 - 38560. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, M. Hadhazy, M. E. Groh, M. T. Wheeler, R. Wollmann, and E. M. McNally Overexpression of gamma -Sarcoglycan Induces Severe Muscular Dystrophy. IMPLICATIONS FOR THE REGULATION OF SARCOGLYCAN ASSEMBLY J. Biol. Chem., June 8, 2001; 276(24): 21785 - 21790. [Abstract] [Full Text] [PDF] |
||||